Bellevue Life Sciences Acquisition Corp

Research Bellevue Life Sciences Acquisition Corp (OSRH) on Bullrun: market cap USD 11.27M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOSRH
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 11.27M
• Financial periodFY2025
• RevenueUSD 2.91M
• Revenue growth-17.7%
• Net income-USD 27.06M
• Gross margin20.4%

Valuation Snapshot

latest market cap is USD 11.27M.

About Bellevue Life Sciences Acquisition Corp

OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1.

Frequently asked questions

What is Bellevue Life Sciences Acquisition Corp's market cap?

Bellevue Life Sciences Acquisition Corp's market capitalization is USD 11.27M.

What does Bellevue Life Sciences Acquisition Corp do?

OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea.